Ultragenyx CEO: FDA Leaders, Review Divisions Out Of Sync On Accelerated Approval For Gene Therapy

 
• By Sarah Karlin-Smith
  
colorful zebras
Ultragenyx CEO not assured by FDA leadership comments on accelerated approval and gene therapy • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Interviews

More from Pink Sheet